Organigram Holdings Inc. (OGI)
After hours:
| Previous close | 1.6600 |
| Open | 1.6500 |
| Bid | 1.6800 x 400 |
| Ask | 1.7100 x 400 |
| Day's range | 1.6500 - 1.6999 |
| 52-week range | 0.9700 - 2.9100 |
| Volume | |
| Avg. volume | 1,591,177 |
| Market cap | 173.956M |
| Beta (5Y monthly) | 1.09 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Organigram Signs Three Year Supply Agreement with Avida Medical in UK
TORONTO, May 28, 2024--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce its second international medical cannabis customer in the UK, Avida Medical, a full-service medical cannabis and specials medicines manufacturing business.
- Business Wire
Organigram Reports Second Quarter Fiscal 2024 Results
TORONTO, May 14, 2024--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced its results for the second quarter ended March 31, 2024 ("Q2 Fiscal 2024").
- Business Wire
Organigram to Report Second Quarter Fiscal 2024 Results on May 14, 2024
TORONTO, May 08, 2024--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the "Company" or "Organigram"), a leading licensed producer of cannabis, announced today it will report earnings results for its second quarter fiscal 2024 ended March 31, 2024, on Tuesday, May 14, 2024, prior to market open.
